Radionuclide therapy / Recep Bekiş, Berna Polack, Murat Fani Bozkurt, editors.
Bekiş, Recep.; Polack, Berna.; Bozkurt, Murat Fani.
2022
RM847
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Radionuclide therapy / Recep Bekiş, Berna Polack, Murat Fani Bozkurt, editors.
Uniform Title Radyonüklit Tedavi. English
ISBN 9783030972202 (electronic bk.)
3030972208 (electronic bk.)
9783030972196
3030972194
DOI https://doi.org/10.1007/978-3-030-97220-2
Publication Details Cham, Switzerland : Springer, 2022.
Language English
Description 1 online resource (387 pages)
Item Number 10.1007/978-3-030-97220-2 doi
Call Number RM847
Dewey Decimal Classification 615.8/42
Summary The main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments. Besides standard methods such as surgery, chemotherapy, radiotherapy, and hormone therapy, newly developed biological treatments, targeted treatments, personalized treatments, external beam radiotherapy, and targeted radionuclide treatments have begun to take their place in professional practice. Nuclear medicine, in addition to its role as a tracer of cancer, also assumes the role of treating with radioactive molecules directed to the cancer it traces. These traceable next-generation radionuclide treatments, whose efficacy and reliability have been proven and where diagnosis, treatment, and follow-up are carried out together, are increasingly included in oncology practice together with the new developed radiopharmaceuticals, ensuring a high rate of damage to cancer cells while protecting the surrounding normal tissues. Molecular cancer treatment will become more effective with individualized next-generation traceable radionuclide treatments, which will be shaped by genetic studies in the future. Radionuclide treatments for many cancer types and benign diseases are presented by experienced nuclear medicine experts in the light of their own experience and case studies, while systemic treatments in common cancer types and side effect management of these treatments are summarized by medical oncologists. This book will be of interest to nuclear medicine physicians as well as oncologists.
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed August 16, 2022).
Added Author Bekiş, Recep.
Polack, Berna.
Bozkurt, Murat Fani.
Available in Other Form Radionuclide Therapy
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Part-1: Basic Information. Basic properties and preparation of radiopharmaceuticals used in radionuclide therapy
Physical Bases of Radionuclide Therapy (Biological Effects and Properties of Particle Radiation)
Fundamentals of radiation safety and dosimetric approach in radionuclide therapy applications. Part-2: Clinical Information: Thyroid Diseases. Radionuclide Therapy in Benign Thyroid Diseases: Nodular Goiter Disease
Radionuclide Therapy in Benign Thyroid Diseases: Graves' Disease
Radionuclide Therapy in Malignant Thyroid Diseases: Differentiated Thyroid Cancer
Radionuclide Therapy in Malignant Thyroid Diseases: Medullary Thyroid Cancer
Systemic Treatments and related side effects in Thyroid Cancer. Part-2: Clinical Information: Neuroendocrine Tumors. Radionuclide Therapy in Neuroendocrine Tumors. Systemic Treatments and related side effects in Neuroendocrine Tumors. Part-4: Clinical Information: Neuroectodermal Tumors. Radionuclide Therapy in Neuroectodermal Tumors
Systemic Treatments and related side effects in Neuroectodermal Tumors. Part-5: Clinical Information: Liver Tumors. Radionuclide Therapy in Liver Tumors. Systemic Treatments and related side effects in Liver Tumors. Part-6: Clinical Information: Prostate Cancer. Radionuclide Therapy in Prostate Cancer
Systemic Treatments and related side effects in Prostate Cancer. Part-7: Clinical Information: Bone and Joint Diseases. Radionuclide Therapy in Joint Diseases: Radiosynovectomy
Radionuclide Pain Palliation Therapy
Radionuclide Therapy with Alpha Emitting Agents in Bone Metastases. Part-8: Clinical Information: Lymphoproliferative Diseases. Radionuclide Therapy in Lymphoproliferative Diseases. Part-9: Radioimmunotherapy. Basics and clinical applications of radioimmunotherapy. Part-10: Intracavitary Radionuclide Therapy. Intracavitary radionuclide applications.

Browse Subjects

Show more subjects...

Statistics

from
to
Export